COVID-19: DCGI nod to Serum Institute of India for phase 2 and 3 human clinical trials of Oxford vaccine candidate

Government officials told PTI that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after a thorough evaluation based on the recommendations of the Subject Expert Committee on -19.

source https://timesofindia.indiatimes.com/india/covid-19-dcgi-nod-to-serum-institute-of-india-for-phase-2-and-3-human-clinical-trials-of-oxford-vaccine-candidate/articleshow/77323830.cms